Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pregabalin provides fast pain relief in postherpetic neuralgia

April 15, 2005

Close proximity of dopaminergic and serotonergic neurons might explain delayed effects of SSRIs

April 15, 2005

Low dopamine receptor availability found in patients with mTLE

April 14, 2005

New data on the antiepileptic efficacy of lacosamide

April 14, 2005

Sodium valproate reported to induce no changes in the PK profile of talampanel

April 14, 2005

Ocaperidone reported effective in schizophrenia

April 14, 2005

FDA requests boxed warnings on atypical antipsychotics

April 14, 2005

Approvable letter for Ambien CR

April 14, 2005

Reminyl renamed Razadyne

April 14, 2005

5-HT1A receptor stimulation reduces damage after cerebral infarction

April 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...